Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)

Por Grunfeld, Eva, Dhesy-Thind, Sukhbinder, Levine, Mark
Publicado em 2005

Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer

Por Tam, V.C., Rask, S., Koru–Sengul, T., Dhesy–Thind, S.
Publicado em 2009

Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists

Por O’Brien, M.A., Dhesy-Thind, S., Charles, C., Hammond Mobilio, M., Leighl, N.B., Grunfeld, E.
Publicado no Curr Oncol (2017)

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine

Por Jerzak, Katarzyna J, Laureano, Marissa, Elsharawi, Radwa, Kavsak, Peter, Chan, Kelvin KW, Dhesy-Thind, Sukhbinder K, Zbuk, Kevin
Publicado no Hypoxia (Auckl) (2017)

Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer

Por Meyers, Brandon M., Al-Shamsi, Humaid O., Rask, Sara, Yelamanchili, Radhika, Phillips, Callista M., Papaioannou, Alexandra, Pond, Gregory R., Jeyabalan, Neera, Zbuk, Kevin M., Dhesy-Thind, Sukhbinder Kaur
Publicado no J Gastrointest Oncol (2017)

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Por Shenouda, Mira M., Gillgrass, Amy, Nham, Tina, Hogg, Richard, Lee, Amanda J., Chew, Marianne V., Shafaei, Mahsa, Aarts, Craig, Lee, Dean A., Hassell, John, Bane, Anita, Dhesy-Thind, Sukhbinder, Ashkar, Ali A.
Publicado no Breast Cancer Res (2017)

(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer

Por You, J J, Cline, K J, Gu, C-S, Pritchard, K I, Dayes, I S, Gulenchyn, K Y, Inculet, R I, Dhesy-Thind, S K, Freeman, M A, Chan, A M, Julian, J A, Levine, M N
Publicado no Br J Cancer (2015)

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity

Por Darryl P. Leong, MBBS, MPH, MBiostat, PhD, Tammy Cosman, PhD, Muhammad M. Alhussein, MD, Nidhi Kumar Tyagi, MBChB, Sarah Karampatos, MS, Carly C. Barron, MD, MS, Douglas Wright, MD, Vikas Tandon, MD, Patrick Magloire, MD, Philip Joseph, MD, David Conen, MD, MPH, P.J. Devereaux, MD, PhD, Peter M. Ellis, MBBS, MMed, PhD, Som D. Mukherjee, MD, MS, Sukhbinder Dhesy-Thind, MD, MS
Publicado em 2019-09-01